Adel Mekhail Sells 9,063 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) EVP Adel Mekhail sold 9,063 shares of Prestige Consumer Healthcare stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $82.00, for a total value of $743,166.00. Following the transaction, the executive vice president now owns 18,365 shares in the company, valued at approximately $1,505,930. This trade represents a 33.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Prestige Consumer Healthcare Stock Performance

PBH opened at $82.36 on Friday. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The firm has a market cap of $4.07 billion, a PE ratio of 20.04, a P/E/G ratio of 2.32 and a beta of 0.47. The business has a fifty day simple moving average of $73.13 and a 200-day simple moving average of $70.18. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $83.83.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm had revenue of $283.79 million for the quarter, compared to analysts’ expectations of $282.09 million. During the same quarter last year, the business posted $1.07 EPS. Prestige Consumer Healthcare’s revenue was down .9% on a year-over-year basis. As a group, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Prestige Consumer Healthcare

Several hedge funds have recently made changes to their positions in PBH. State Board of Administration of Florida Retirement System grew its position in Prestige Consumer Healthcare by 77.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after purchasing an additional 11,000 shares in the last quarter. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Prestige Consumer Healthcare in the second quarter worth $550,000. CANADA LIFE ASSURANCE Co grew its holdings in shares of Prestige Consumer Healthcare by 19.4% during the first quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock valued at $3,453,000 after buying an additional 7,715 shares in the last quarter. Sequoia Financial Advisors LLC raised its position in Prestige Consumer Healthcare by 12.9% during the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock valued at $708,000 after buying an additional 1,120 shares during the period. Finally, Atria Investments Inc purchased a new stake in Prestige Consumer Healthcare in the 1st quarter worth about $1,246,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. DA Davidson reaffirmed a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. Jefferies Financial Group restated a “hold” rating and set a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.67.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.